Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Veterinary Equipment Disposables Market

ID: MRFR/MED/48682-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

South America Veterinary Equipment and Disposables Market Research Report By Type (Anesthesia Equipment, Critical Care Consumables, Temperature Management Equipment, Fluid Management Equipment, Patient Monitoring Equipment, Research Equipment, Rescue & Resuscitation Equipment, Others), By Animal Type (Small Animals, Large Animals), By End-User (Veterinary Clinics, Veterinary Hospitals, Research Institutes, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Veterinary Equipment Disposables Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Surgical Equipment
  50.     4.1.2 Diagnostic Equipment
  51.     4.1.3 Monitoring Equipment
  52.     4.1.4 Therapeutic Equipment
  53.     4.1.5 Anesthesia Equipment
  54.   4.2 Healthcare, BY End Use (USD Million)
  55.     4.2.1 Veterinary Clinics
  56.     4.2.2 Animal Hospitals
  57.     4.2.3 Research Laboratories
  58.     4.2.4 Farm Animal Care
  59.     4.2.5 Pet Care Facilities
  60.   4.3 Healthcare, BY Product Type (USD Million)
  61.     4.3.1 Surgical Instruments
  62.     4.3.2 Diagnostic Devices
  63.     4.3.3 Anesthesia Machines
  64.     4.3.4 Monitoring Devices
  65.     4.3.5 Consumables
  66.   4.4 Healthcare, BY Animal Type (USD Million)
  67.     4.4.1 Companion Animals
  68.     4.4.2 Livestock
  69.     4.4.3 Equine
  70.     4.4.4 Exotic Animals
  71.     4.4.5 Laboratory Animals
  72.   4.5 Healthcare, BY Distribution Channel (USD Million)
  73.     4.5.1 Online Sales
  74.     4.5.2 Retail Sales
  75.     4.5.3 Direct Sales
  76.     4.5.4 Veterinary Distributors
  77.     4.5.5 Wholesale
  78. 5 SECTION V: COMPETITIVE ANALYSIS
  79.   5.1 Competitive Landscape
  80.     5.1.1 Overview
  81.     5.1.2 Competitive Analysis
  82.     5.1.3 Market share Analysis
  83.     5.1.4 Major Growth Strategy in the Healthcare
  84.     5.1.5 Competitive Benchmarking
  85.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  86.     5.1.7 Key developments and growth strategies
  87.       5.1.7.1 New Product Launch/Service Deployment
  88.       5.1.7.2 Merger & Acquisitions
  89.       5.1.7.3 Joint Ventures
  90.     5.1.8 Major Players Financial Matrix
  91.       5.1.8.1 Sales and Operating Income
  92.       5.1.8.2 Major Players R&D Expenditure. 2023
  93.   5.2 Company Profiles
  94.     5.2.1 Zoetis (US)
  95.       5.2.1.1 Financial Overview
  96.       5.2.1.2 Products Offered
  97.       5.2.1.3 Key Developments
  98.       5.2.1.4 SWOT Analysis
  99.       5.2.1.5 Key Strategies
  100.     5.2.2 Boehringer Ingelheim (DE)
  101.       5.2.2.1 Financial Overview
  102.       5.2.2.2 Products Offered
  103.       5.2.2.3 Key Developments
  104.       5.2.2.4 SWOT Analysis
  105.       5.2.2.5 Key Strategies
  106.     5.2.3 Merck Animal Health (US)
  107.       5.2.3.1 Financial Overview
  108.       5.2.3.2 Products Offered
  109.       5.2.3.3 Key Developments
  110.       5.2.3.4 SWOT Analysis
  111.       5.2.3.5 Key Strategies
  112.     5.2.4 Elanco Animal Health (US)
  113.       5.2.4.1 Financial Overview
  114.       5.2.4.2 Products Offered
  115.       5.2.4.3 Key Developments
  116.       5.2.4.4 SWOT Analysis
  117.       5.2.4.5 Key Strategies
  118.     5.2.5 Virbac (FR)
  119.       5.2.5.1 Financial Overview
  120.       5.2.5.2 Products Offered
  121.       5.2.5.3 Key Developments
  122.       5.2.5.4 SWOT Analysis
  123.       5.2.5.5 Key Strategies
  124.     5.2.6 Cegelec (BR)
  125.       5.2.6.1 Financial Overview
  126.       5.2.6.2 Products Offered
  127.       5.2.6.3 Key Developments
  128.       5.2.6.4 SWOT Analysis
  129.       5.2.6.5 Key Strategies
  130.     5.2.7 Heska Corporation (US)
  131.       5.2.7.1 Financial Overview
  132.       5.2.7.2 Products Offered
  133.       5.2.7.3 Key Developments
  134.       5.2.7.4 SWOT Analysis
  135.       5.2.7.5 Key Strategies
  136.     5.2.8 IDEXX Laboratories (US)
  137.       5.2.8.1 Financial Overview
  138.       5.2.8.2 Products Offered
  139.       5.2.8.3 Key Developments
  140.       5.2.8.4 SWOT Analysis
  141.       5.2.8.5 Key Strategies
  142.     5.2.9 Neogen Corporation (US)
  143.       5.2.9.1 Financial Overview
  144.       5.2.9.2 Products Offered
  145.       5.2.9.3 Key Developments
  146.       5.2.9.4 SWOT Analysis
  147.       5.2.9.5 Key Strategies
  148.   5.3 Appendix
  149.     5.3.1 References
  150.     5.3.2 Related Reports
  151. 6 LIST OF FIGURES
  152.   6.1 MARKET SYNOPSIS
  153.   6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  154.   6.3 SOUTH AMERICA MARKET ANALYSIS BY END USE
  155.   6.4 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
  156.   6.5 SOUTH AMERICA MARKET ANALYSIS BY ANIMAL TYPE
  157.   6.6 SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  158.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  159.   6.8 RESEARCH PROCESS OF MRFR
  160.   6.9 DRO ANALYSIS OF HEALTHCARE
  161.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  162.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  163.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  164.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  165.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  166.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  167.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  168.   6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  169.   6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
  170.   6.19 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
  171.   6.20 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Million)
  172.   6.21 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  173.   6.22 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  174.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  175. 7 LIST OF TABLES
  176.   7.1 LIST OF ASSUMPTIONS
  177.     7.1.1
  178.   7.2 South America MARKET SIZE ESTIMATES; FORECAST
  179.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  180.     7.2.2 BY END USE, 2026-2035 (USD Million)
  181.     7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
  182.     7.2.4 BY ANIMAL TYPE, 2026-2035 (USD Million)
  183.     7.2.5 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
  184.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  185.     7.3.1
  186.   7.4 ACQUISITION/PARTNERSHIP
  187.     7.4.1

South America Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

  • Surgical Equipment
  • Diagnostic Equipment
  • Monitoring Equipment
  • Therapeutic Equipment
  • Anesthesia Equipment

Healthcare By End Use (USD Million, 2026-2035)

  • Veterinary Clinics
  • Animal Hospitals
  • Research Laboratories
  • Farm Animal Care
  • Pet Care Facilities

Healthcare By Product Type (USD Million, 2026-2035)

  • Surgical Instruments
  • Diagnostic Devices
  • Anesthesia Machines
  • Monitoring Devices
  • Consumables

Healthcare By Animal Type (USD Million, 2026-2035)

  • Companion Animals
  • Livestock
  • Equine
  • Exotic Animals
  • Laboratory Animals

Healthcare By Distribution Channel (USD Million, 2026-2035)

  • Online Sales
  • Retail Sales
  • Direct Sales
  • Veterinary Distributors
  • Wholesale

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions